Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study.

Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Sørensen A, Frydland M, Lassen AT, Udesen NLJ, Schmidt H, Ravn HB, Møller JE.

Eur J Heart Fail. 2019 Jul 24. doi: 10.1002/ejhf.1566. [Epub ahead of print]

PMID:
31339222
2.

Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.

Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J.

Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952. [Epub ahead of print]

PMID:
31315939
3.

Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data.

Nabi H, Rørth R, Tajchman Mb DH, Holmvang L, Torp-Pedersen C, Gislason G, Fosbøl EL, Køber L, Sørensen R.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 5. pii: pvz025. doi: 10.1093/ehjcvp/pvz025. [Epub ahead of print]

PMID:
31274145
4.

Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.

Udesen NJ, Møller JE, Lindholm MG, Eiskjær H, Schäfer A, Werner N, Holmvang L, Terkelsen CJ, Jensen LO, Junker A, Schmidt H, Wachtell K, Thiele H, Engstrøm T, Hassager C; DanGer Shock investigators.

Am Heart J. 2019 Aug;214:60-68. doi: 10.1016/j.ahj.2019.04.019. Epub 2019 May 6.

5.

2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.

Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W; TARGET AC Investigators.

JACC Cardiovasc Interv. 2019 May 22. pii: S1936-8798(19)31027-1. doi: 10.1016/j.jcin.2019.05.001. [Epub ahead of print]

PMID:
31129092
6.

Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Raungaard B, Terkelsen CJ, Jensen LO, Sadjadieh G, Engstrøm T.

Int J Cardiol. 2019 Aug 15;289:1-5. doi: 10.1016/j.ijcard.2019.04.064. Epub 2019 May 1.

PMID:
31078351
7.

Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction.

Klein A, Wiberg S, Hassager C, Winther-Jensen M, Frikke-Schmidt R, Bang LE, Lindholm MG, Holmvang L, Moeller-Helgestad O, Ravn HB, Jensen LO, Kjaergaard J, Moeller JE, Frydland M.

Shock. 2019 May 1. doi: 10.1097/SHK.0000000000001369. [Epub ahead of print]

PMID:
31058719
8.

Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.

Kyhl K, Ahtarovski KA, Nepper-Christensen L, Ekström K, Ghotbi AA, Schoos M, Göransson C, Bertelsen L, Helqvist S, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Høfsten DE, Køber L, Kelbæk H, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.

PMID:
31000010
9.

Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

Kwok CS, Shah B, Al-Suwaidi J, Fischman DL, Holmvang L, Alraies C, Bagur R, Nagaraja V, Rashid M, Mohamed M, Martin GP, Kontopantelis E, Kinnaird T, Mamas M.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):734-748. doi: 10.1016/j.jcin.2019.02.007. Epub 2019 Mar 27.

PMID:
30928446
10.

Cardiac Autonomic Function Is Associated With Myocardial Flow Reserve in Type 1 Diabetes.

Zobel EH, Hasbak P, Winther SA, Hansen CS, Fleischer J, von Scholten BJ, Holmvang L, Kjaer A, Rossing P, Hansen TW.

Diabetes. 2019 Jun;68(6):1277-1286. doi: 10.2337/db18-1313. Epub 2019 Mar 12.

PMID:
30862683
11.

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted HH, Raungaard B, Jørgensen E, Køber L, Høfsten DE, Kelbæk H, Engstrøm T.

EuroIntervention. 2019 Jun 20;15(2):172-179. doi: 10.4244/EIJ-D-18-00766.

12.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, Torp-Pedersen C, Høfsten D, Kløvgaard L, Holmvang L, Helqvist S, Jørgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Køber LV, Engstrøm T.

Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152. Erratum in: Circulation. 2018 Dec 11;138(24):e750.

PMID:
30565996
13.

Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.

Räber L, Koskinas KC, Yamaji K, Taniwaki M, Roffi M, Holmvang L, Garcia Garcia HM, Zanchin T, Maldonado R, Moschovitis A, Pedrazzini G, Zaugg S, Dijkstra J, Matter CM, Serruys PW, Lüscher TF, Kelbaek H, Karagiannis A, Radu MD, Windecker S.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1518-1528. doi: 10.1016/j.jcmg.2018.08.024. Epub 2018 Dec 12.

PMID:
30553686
14.

Myocardial flow reserve assessed by cardiac 82Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetes.

Zobel EH, Winther SA, Hasbak P, von Scholten BJ, Holmvang L, Kjaer A, Rossing P, Hansen TW.

Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):796-803. doi: 10.1093/ehjci/jey174.

15.

Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.

Potts JE, Iliescu CA, Lopez Mattei JC, Martinez SC, Holmvang L, Ludman P, De Belder MA, Kwok CS, Rashid M, Fischman DL, Mamas MA.

Eur Heart J. 2019 Jun 7;40(22):1790-1800. doi: 10.1093/eurheartj/ehy769.

PMID:
30500952
16.

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Bang LE, Helqvist S, Kyhl K, Køber L, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.

PMID:
30354595
17.

Lactate is a Prognostic Factor in Patients Admitted With Suspected ST-Elevation Myocardial Infarction.

Frydland M, Møller JE, Wiberg S, Lindholm MG, Hansen R, Henriques JPS, Møller-Helgestad OK, Bang LE, Frikke-Schmidt R, Goetze JP, Udesen NLJ, Thomsen JH, Ouweneel DM, Obling L, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C.

Shock. 2019 Mar;51(3):321-327. doi: 10.1097/SHK.0000000000001191.

PMID:
30286032
18.

Posture changes platelet inhibition time after ingestion of prasugrel.

Antonsen J, Bundgaard N, Holmvang L, Engstrøm T, Iversen K.

Dan Med J. 2018 Oct;65(10). pii: A5504.

PMID:
30269747
19.

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.

Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Baumbach A; TARGET All Comers Investigators.

Lancet. 2018 Sep 29;392(10153):1117-1126. doi: 10.1016/S0140-6736(18)31649-0. Epub 2018 Sep 3.

PMID:
30190206
20.

Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: Insights from 6.6 million PCI procedures in the United States.

Potts J, Sirker A, Martinez SC, Gulati M, Alasnag M, Rashid M, Kwok CS, Ensor J, Burke DL, Riley RD, Holmvang L, Mamas MA.

PLoS One. 2018 Sep 4;13(9):e0203325. doi: 10.1371/journal.pone.0203325. eCollection 2018.

21.

Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Schoos MM, Göransson C, Laursen PN, Sadjadieh G, Ghotbi AA, Bertelsen L, Køber L, Helqvist S, Pedersen F, Jørgensen E, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):318-328. doi: 10.1177/2048872618795515. Epub 2018 Aug 23.

PMID:
30136597
22.

Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients.

Sadjadieh G, Engstrøm T, Høfsten DE, Helqvist S, Køber L, Pedersen F, Laursen PN, Andersson HB, Nepper-Christensen L, Clemmensen P, Sørensen R, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Oct 15;122(8):1287-1296. doi: 10.1016/j.amjcard.2018.07.008. Epub 2018 Jul 19.

PMID:
30115422
23.

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T.

Am Heart J. 2018 Oct;204:128-138. doi: 10.1016/j.ahj.2018.05.018. Epub 2018 Aug 10.

PMID:
30103092
24.

Peripheral Arterial Disease in Women: an Overview of Risk Factor Profile, Clinical Features, and Outcomes.

Jelani QU, Petrov M, Martinez SC, Holmvang L, Al-Shaibi K, Alasnag M.

Curr Atheroscler Rep. 2018 Jun 2;20(8):40. doi: 10.1007/s11883-018-0742-x.

25.

MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.

Falkentoft AC, Rørth R, Iversen K, Høfsten DE, Kelbæk H, Holmvang L, Frydland M, Schoos MM, Helqvist S, Axelsson A, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Pedersen F, Torp-Pedersen C, Kofoed KF, Goetze JP, Engstrøm T, Køber L.

J Am Heart Assoc. 2018 May 18;7(11). pii: e008123. doi: 10.1161/JAHA.117.008123.

26.

Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR; ICPC Investigators.

Am Heart J. 2018 Apr;198:152-159. doi: 10.1016/j.ahj.2017.12.010. Epub 2017 Dec 17. Review.

27.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
28.

Plasma Concentration of Biomarkers Reflecting Endothelial Cell- and Glycocalyx Damage are Increased in Patients With Suspected ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.

Frydland M, Ostrowski SR, Møller JE, Hadziselimovic E, Holmvang L, Ravn HB, Jensen LO, Pettersson AS, Kjaergaard J, Lindholm MG, Johansson PI, Hassager C.

Shock. 2018 Nov;50(5):538-544. doi: 10.1097/SHK.0000000000001123.

PMID:
29438221
29.

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy).

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Laursen PN, Nepper-Christensen L, Clemmensen P, Møller-Helgestad OK, Sørensen R, Ravkilde J, Terkelsen CJ, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Apr 1;121(7):781-788. doi: 10.1016/j.amjcard.2017.12.019. Epub 2018 Jan 12.

PMID:
29402421
30.

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

EuroIntervention. 2018 Aug 20;14(6):700-707. doi: 10.4244/EIJ-D-17-00857.

31.

Association between QRS duration on prehospital ECG and mortality in patients with suspected STEMI.

Hansen R, Frydland M, Møller-Helgestad OK, Lindholm MG, Jensen LO, Holmvang L, Ravn HB, Kjærgaard J, Hassager C, Møller JE.

Int J Cardiol. 2017 Dec 15;249:55-60. doi: 10.1016/j.ijcard.2017.07.049.

PMID:
29121757
32.

[Extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital refractory cardiac arrest].

Obling L, Wiberg S, Møller JE, Hassager C, Terkelsen CJ, Holmvang L, Aarøe J, Møller-Sørensen H, Fjølner J, Rudolph SS, Kjaergaard J.

Ugeskr Laeger. 2017 Oct 30;179(44). pii: V04170293. Review. Danish.

PMID:
29084620
33.

Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Andersson HB, Pedersen F, Engstrøm T, Helqvist S, Jensen MK, Jørgensen E, Kelbæk H, Räder SBEW, Saunamäki K, Bates E, Grande P, Holmvang L, Clemmensen P.

Eur Heart J. 2018 Jan 7;39(2):102-110. doi: 10.1093/eurheartj/ehx491.

PMID:
29029035
34.

Data on association between QRS duration on prehospital ECG and mortality in patients with confirmed STEMI.

Hansen R, Frydland M, Møller-Helgestad OK, Lindholm MG, Jensen LO, Holmvang L, Ravn HB, Kjærgaard J, Hassager C, Møller JE.

Data Brief. 2017 Sep 5;15:12-17. doi: 10.1016/j.dib.2017.08.051. eCollection 2017 Dec.

35.

Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients.

Ghotbi AA, Hasbak P, Nepper-Christensen L, Lønborg J, Atharovski K, Christensen T, Holmvang L, Engstrøm T, Ripa RS, Kjær A.

J Nucl Cardiol. 2019 Apr;26(2):471-482. doi: 10.1007/s12350-017-0993-x. Epub 2017 Jul 17.

36.

Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.

Lønborg J, Engstrøm T, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Vejlstrup N, Kyhl K, Schoos MM, Ghotbi A, Göransson C, Bertelsen L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Kløvgaard L, Høfsten DE, Køber L, Kelbæk H; DANAMI-3 Investigators.

J Am Coll Cardiol. 2017 Jun 13;69(23):2794-2804. doi: 10.1016/j.jacc.2017.03.601.

37.

Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.

Obling L, Frydland M, Hansen R, Møller-Helgestad OK, Lindholm MG, Holmvang L, Ravn HB, Wiberg S, Thomsen JH, Jensen LO, Kjærgaard J, Møller JE, Hassager C.

Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):7-15. doi: 10.1177/2048872617706503. Epub 2017 Apr 28.

PMID:
28452562
38.

Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).

Lønborg J, Engstrøm T, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L, Høfsten DE; DANAMI 3-PRIMULTI Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460.

PMID:
28404623
39.

Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study.

Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Holmvang L, Pedersen F, Clemmensen P, Saünamaki K, Jørgensen E, Kyhl K, Ghotbi A, Schoos MM, Göransson C, Bertelsen L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004467. doi: 10.1161/CIRCINTERVENTIONS.116.004467.

PMID:
28264870
40.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

41.

The effect of TIcagrelor administered through a nasogastric tube to COMAtose patients undergoing acute percutaneous coronary intervention: the TICOMA study.

Ratcovich H, Sadjadieh G, Andersson HB, Frydland M, Wiberg S, Dridi NP, Kjaergaard J, Holmvang L.

EuroIntervention. 2017 Feb 20;12(14):1782-1788. doi: 10.4244/EIJ-D-16-00398.

42.

Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints.

Laursen PN, Holmvang L, Kelbæk H, Vejlstrup N, Engstrøm T, Lønborg J.

Clin Res Cardiol. 2017 Jul;106(7):525-532. doi: 10.1007/s00392-017-1081-6. Epub 2017 Feb 6.

PMID:
28168513
43.

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Ghotbi AA, Schoos MM, Göransson C, Bertelsen L, Køber L, Helqvist S, Pedersen F, Saünamaki K, Jørgensen E, Kelbæk H, Holmvang L, Vejlstrup N, Engstrøm T.

J Am Heart Assoc. 2017 Jan 9;6(1). pii: e004823. doi: 10.1161/JAHA.116.004823.

44.

The Authors Reply.

Christensen TE, Bang LE, Holmvang L, Skovgaard DC, Oturai DB, Søholm H, Thomsen JH, Andersson HB, Ghotbi AA, Ihlemann N, Kjaer A, Hasbak P.

JACC Cardiovasc Imaging. 2017 Jan;10(1):96-97. doi: 10.1016/j.jcmg.2016.08.017. No abstract available.

45.

The Authors Reply.

Christensen TE, Bang LE, Holmvang L, Skovgaard DC, Oturai DB, Søholm H, Thomsen JH, Andersson HB, Ghotbi AA, Ihlemann N, Kjaer A, Hasbak P.

JACC Cardiovasc Imaging. 2017 Jan;10(1):94-95. doi: 10.1016/j.jcmg.2016.08.019. No abstract available.

46.

Outcome After Surgery for Acute Aortic Dissection: Influence of Preoperative Antiplatelet Therapy on Prognosis.

Chemtob RA, Moeller-Soerensen H, Holmvang L, Olsen PS, Ravn HB.

J Cardiothorac Vasc Anesth. 2017 Apr;31(2):569-574. doi: 10.1053/j.jvca.2016.10.007. Epub 2016 Oct 11.

PMID:
28017673
47.

Dr. Galen Wagner (1939-2016) as an Academic Writer: An Overview of his Peer-reviewed Scientific Publications.

Pahlm O, Swenne CA, Man S, Fakhri Y, Atwater BD, Bacharova L, Bang L, Birnbaum Y, Carlsson E, Clemmensen P, Engblom H, Gettes LS, Grande P, Hakacova N, Holmvang L, Jurlander B, Loring Z, Pahlm U, Pettersson J, Ringborn M, Risum N, Sejersten-Ripa M, Sörnmo L, Strauss DG, Zusterzeel R, Warren SG.

J Electrocardiol. 2017 Jan - Feb;50(1):47-73. doi: 10.1016/j.jelectrocard.2016.11.008. Epub 2016 Nov 11. No abstract available.

PMID:
28010929
48.

Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

EuroIntervention. 2016 Nov 20;12(10):1231-1238. doi: 10.4244/EIJV12I10A203.

49.

Subacute cardiac rubidium-82 positron emission tomography (82Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMI.

Ghotbi AA, Kjaer A, Nepper-Christensen L, Ahtarovski KA, Lønborg JT, Vejlstrup N, Kyhl K, Christensen TE, Engstrøm T, Kelbæk H, Holmvang L, Bang LE, Ripa RS, Hasbak P.

J Nucl Cardiol. 2018 Jun;25(3):970-981. doi: 10.1007/s12350-016-0694-x. Epub 2016 Oct 14.

50.

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction.

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker HE, Clemmensen P, Køber L, Treiman M, Engstrøm T.

EuroIntervention. 2016 Jul 20;12(4):449-55. doi: 10.4244/EIJV12I4A78.

Supplemental Content

Loading ...
Support Center